Alan Kania

Alan Kania

Auto-generated profile, based on publicly available information

Alan Kania

Department of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2023 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
TQTongrui Qian
Tongrui Qian
HWHuan Wang
Huan Wang
PWPeng Wang
Peng Wang
LGLan Geng
Lan Geng
LMLong Mei
Long Mei
YLYulong Li
Yulong Li

24 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MIMai Iwasaki
Mai Iwasaki
ALArthur Lefevre
Arthur Lefevre
FAFerdinand Althammer
Ferdinand Althammer
ECEtienne Clauss Creusot
Etienne Clauss Creusot
OŁOlga Łąpieś
Olga Łąpieś
ACAlexandre Charlet
Alexandre Charlet
The hypothalamic neuropeptide oxytocin (OT) exerts prominent analgesic effects via central and peripheral action. However, the precise analgesic pathways recruited by OT are largely elusive. Here we discovered a subset of OT neurons whose projections preferentially terminate on OT receptor (OTR)-expressing neurons in the ventrolateral periaqueductal gray (vlPAG). Using a newly generated line of transgenic rats (OTR-IRES-Cre), we determined that most of the vlPAG OTR expressing cells targeted by OT projections are GABAergic. Ex vivo stimulation of parvocellular OT axons in the vlPAG induced local OT release, as measured with OT sensor GRAB. In vivo, optogenetically-evoked axonal OT release in the vlPAG of as well as chemogenetic activation of OTR vlPAG neurons resulted in a long-lasting increase of vlPAG neuronal activity. This lead to an indirect suppression of sensory neuron activity in the spinal cord and strong analgesia in both female and male rats. Altogether, we describe an OT-vlPAG-spinal cord circuit that is critical for analgesia in both inflammatory and neuropathic pain models.

27 February 2017 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
AKAlan Kania
Alan Kania
AGAnna Gugula
Anna Gugula
AGAgnieszka Grabowiecka
Agnieszka Grabowiecka
CÁCamila de Ávila
Camila de Ávila
TBTomasz Blasiak
Tomasz Blasiak
ABAnna Blasiak
Anna Blasiak

1 December 2015 in Neuropharmacology
Verified
Journal Article
Closed access
ABAnna Blasiak
Anna Blasiak
MSMarcin Siwiec
Marcin Siwiec
AGAgnieszka Grabowiecka
Agnieszka Grabowiecka
TBTomasz Blasiak
Tomasz Blasiak
ACAnna Czerw
Anna Czerw
AGAndrew L. Gundlach
Andrew L. Gundlach

12 June 2020 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
AKAlan Kania
Alan Kania
ASAgata Szlaga
Agata Szlaga
PSPatryk Sambak
Patryk Sambak
AGAnna Gugula
Anna Gugula
EBEwa Blasiak
Ewa Blasiak
ABAnna Blasiak
Anna Blasiak
Binge-eating disorder is the most common eating disorder. Various neuropeptides play important roles in the regulation of feeding behavior, including relaxin-3 (RLN3), which stimulates food intake in rats through the activation of the relaxin-family peptide-3 receptor (RXFP3). Here we demonstrate that a likely mechanism underlying the orexigenic action of RLN3 is RXFP3-mediated inhibition of oxytocin- and arginine-vasopressin-synthesizing paraventricular nucleus (PVN) magnocellular neurosecretory cells. Moreover, we reveal that, in male and female rats, this action depends on M-like potassium conductance. Notably, higher intra- and peri-PVN RLN3 fiber densities were observed in females, which may constitute an anatomic substrate for observed sex differences in binge-eating disorder. Finally, in a model of binge-eating in female rats, RXFP3 blockade within the PVN prevented binge-eating behavior. These data demonstrate a direct RLN3/RXFP3 action in the PVN of male and female rats, identify the associated ionic mechanisms, and reveal that hypothalamic RLN3/RXFP3 signaling regulates binge-eating behavior. SIGNIFICANCE STATEMENT Binge-eating disorder is the most common eating disorder worldwide, affecting women twice as frequently as men. Various neuropeptides play important roles in the regulation of feeding behavior, including relaxin-3, which acts via the relaxin-family peptide-3 receptor (RXFP3). Using a model of binge-eating, we demonstrated that relaxin-3/RXFP3 signaling in the hypothalamic paraventricular nucleus (PVN) is necessary for the expression of binge-eating behavior in female rats. Moreover, we elucidated the neuronal mechanism of RLN3/RXFP3 signaling in PVN in male and female rats and characterized sex differences in the RLN3 innervation of the PVN. These findings increase our understanding of the brain circuits and neurotransmitters involved in binge-eating disorder pathology and identify RXFP3 as a therapeutic target for binge-like eating disorders.

4 December 2014 in Journal of Natural Products
Verified
Journal Article
Closed access
MCMarta Magdalena Czyzewska
Marta Magdalena Czyzewska
LCLukasz Chrobok
Lukasz Chrobok
AKAlan Kania
Alan Kania
MJMagdalena Jatczak
Magdalena Jatczak
FPFederica Pollastro
Federica Pollastro
JMJerzy Mozrzymas
Jerzy Mozrzymas